DaVita (DVA) Tops Q2 EPS by 17c; offers guidance
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $210.93 +0.60%
EPS Growth %: +29.2%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +29.2%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q2 EPS of $2.95, $0.17 better than the analyst estimate of $2.78. Revenue for the quarter came in at $3.38 billion versus the consensus estimate of $3.36 billion.
GUIDANCE:
DaVita sees FY2025 EPS of $10.20-$11.30, versus the consensus of $10.71.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- Lockheed Martin wins $8.4B missile contract modification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
